BridgeBio Oncology Therapeutics (BBOT) Operating Expenses (2024 - 2026)
BridgeBio Oncology Therapeutics (BBOT) reported Operating Expenses of $60.19 million for Q2 2026, up 100.0% from $30.09 million a year earlier and up 30.3% from the prior quarter.
Powered by 
Analysis
BridgeBio Oncology Therapeutics (BBOT) Operating Expenses (2024 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BridgeBio Oncology Therapeutics' Operating Expenses came in at $198.96 million, up 109.9% year-over-year; for FY2025, it came in at $145.82 million, up 80.3% from FY2024.
- By year, Operating Expenses came in at $80.86 million in FY2024 and $41,692 in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Operating Expenses in data going back to Q1 2024.
- Year over year, Operating Expenses has now increased in each of the last four quarters, with growth averaging 112.0% over the last four quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $46.18 million (Q1 2026), $43.41 million (Q4 2025) and $49.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.09 Bn |
| 10 | BridgeBio Oncology Therapeutics | 305.24 Mn | -1.07 Bn | - | 60.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.19 Mn |
| Mar 31, 2026 | 46.18 Mn |
| Dec 31, 2025 | 43.41 Mn |
| Sep 30, 2025 | 49.18 Mn |
| Jun 30, 2025 | 30.09 Mn |
| Mar 31, 2025 | 23.14 Mn |
| Dec 31, 2024 | 21.88 Mn |
| Sep 30, 2024 | 19.66 Mn |
| Jun 30, 2024 | 152,343.00 |
| Mar 31, 2024 | 66,701.00 |
API Access
BridgeBio Oncology Therapeutics Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=BBOT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "BBOT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=BBOT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();